[Severe epistaxis secondary to ticlopidine. Report of 3 cases].

Abstract

Ticlopidine (Ticlid@) is a platelet aggregation inhibitor that can produce bleeding or severe hemorrhage as a side-effect. The cases of three patients on previous treatment with that drug that required admission in our hospital because of recurrent epistaxis are reported. We have analysed their personal antecedents, complementary explorations, type of nasal packing used, clinical evolution and stay.

• Authors: V Pino Rivero, M Marcos García, G Trinidad Ruíz, T Keituqwa Yáñez, G Pardo Romero, A González Palomino, A Blasco Huelva
• Journal: Anales otorrinolaringologicos ibero-americanos (An Otorrinolaringol Ibero Am) Vol. 31 Issue 4 Pg. 365-71 ( 2004) ISSN: 0303-8874 [Print] Spain
• Vernacular Title: Epístaxis intensa secundaria a ticlopidina. Presentación de 3 casos.
• PMID: 15382488 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Platelet Aggregation Inhibitors
• Ticlopidine

Topics

• Aged
• Aged, 80 and over
• Epistaxis (chemically induced, diagnosis, therapy)
• Humans
• Male
• Platelet Aggregation Inhibitors (administration & dosage, adverse effects)
• Tampons, Surgical
• Ticlopidine (administration & dosage, adverse effects)
• Treatment Outcome